Dr. Michelle E. Fullard, MD

Dr. Fullard practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Fullard's NPI, 1356665194, was assigned on March 23, 2010. Dr. Fullard graduated from Vanderbilt University School of Medicine in 2010. Dr. Fullard holds Colorado license DR.0060575.

Dr. Fullard's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Fullard's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. The medical group on file is University of Colorado Medicine (CU Medicine).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fullard practices. Vendor and product names are available with a free account.

Neurology is Dr. Fullard's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Fullard is licensed in Colorado.

CMS data shows 326 Medicare services from Dr. Fullard across 6 procedure codes in 2024, for 113 Medicare patients. Medicare paid $18,525 for them.

CMS counts 113 Medicare patients who saw Dr. Fullard in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have parkinson's disease, and 58% have arthritis. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fullard's median patient age at 75, with 51% women.

In 2024, Dr. Fullard wrote 696 Medicare Part D claims for 130 patients. 88% of them were for generic drugs. CMS names the drug for 578 of them, across 17 drugs with 11 or more claims each, at $143,382 in total drug cost. In 2023, CMS named 517 claims across 15 drugs.

Dr. Fullard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fullard as offering telehealth.

Dmand AI links 21 papers to Dr. Fullard, published from 2015 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Parkinson Disease, Cognitive Dysfunction and Medicare. Dr. Fullard has published most often in J Parkinsons Dis. Dr. Fullard's most frequent co-authors are John Eric Duda, MD, James Morley, MD and Daniel Weintraub, MD.

CMS Open Payments shows 8 general payments to Dr. Fullard from 5 drug and device companies from 2016 to 2024. Grants make up the largest share, 70% of the total. Eli Lilly and Company paid the most, $1,000. It also lists 1 research payment totaling $5,120 in 2023.

Dr. Fullard graduated from Vanderbilt University School of Medicine in 2010.